Publication | Open Access
Phase I/II dose-finding, safety and efficacy study of radium-223 dichloride in renal cell carcinoma patients with bone metastases
44
Citations
0
References
2016
Year
UrologyOncologyPhase I/ii Dose-findingGenitourinary CancerMedicineCancer TreatmentPharmacologyRadiation OncologyNuclear MedicineEfficacy StudyRadium-223 Dichloride
No additional data available for this publication yet. Check back later!